mesalamine has been researched along with pectins in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (35.29) | 29.6817 |
| 2010's | 7 (41.18) | 24.3611 |
| 2020's | 4 (23.53) | 2.80 |
| Authors | Studies |
|---|---|
| Turkoglu, M; Ugurlu, T | 1 |
| Luangtana-Anan, M; Nunthanid, J; Sriamornsak, P; Wanchana, S | 1 |
| Ahmed, IS | 1 |
| Dongmei, C; Fude, C; Hongze, P; Jie, J; Lei, Y; Wenhui, L | 1 |
| Fassihi, R; Talukder, RM | 1 |
| Band, J; Connolly, SM; Hodges, LA; O'Mahony, B; Stevens, HN; Turkoglu, M; Ugurlu, T; Wilson, CG | 1 |
| Patel, JK; Patel, NV; Shah, SH | 1 |
| Hu, W; Jia, Y; Jiang, H; Liu, J; Zhang, J; Zhang, L | 1 |
| Bawa, P; Choonara, YE; du Toit, LC; Kumar, P; Meyer, LC; Ndesendo, VM; Pillay, V | 1 |
| Alcântara, AC; Aranda, P; Araújo-Moreira, FM; Darder, M; Ribeiro, LN; Ruiz-Hitzky, E | 1 |
| Bansal, D; Dubey, N; Ganeshpurkar, A; Pandey, V; Vishwakarma, N | 1 |
| Lakshmanan, P; Newton, AM | 1 |
| Bajaj, AN; Deshpande, SG; Nikam, VS; Sawarkar, SP | 1 |
| Lakshmanan, P; Newton, AMJ | 1 |
| Musiał, W; Potempa, A; Wójcik-Pastuszka, D | 1 |
| Mandal, UK; Narang, RK; Singh, A | 1 |
| Cerea, M; Dubuquoy, C; Dubuquoy, L; Foppoli, A; Gazzaniga, A; Maroni, A; Moutaharrik, S; Neut, C; Palugan, L; Siepmann, F; Siepmann, J | 1 |
1 trial(s) available for mesalamine and pectins
| Article | Year |
|---|---|
Scintigraphic evaluation of colon targeting pectin-HPMC tablets in healthy volunteers.
Topics: Administration, Oral; Adult; Colon; Colon, Ascending; Colon, Transverse; Compressive Strength; Drug Delivery Systems; Gastric Emptying; Gastrointestinal Transit; Humans; Hypromellose Derivatives; Male; Mesalamine; Methylcellulose; Middle Aged; Nisin; Pectins; Permeability; Pilot Projects; Radionuclide Imaging; Tablets; Technetium Tc 99m Pentetate | 2009 |
16 other study(ies) available for mesalamine and pectins
| Article | Year |
|---|---|
In vitro evaluation of pectin-HPMC compression coated 5-aminosalicylic acid tablets for colonic delivery.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antidiarrheals; Colon; Compressive Strength; Drug Delivery Systems; Drug Evaluation, Preclinical; Lactose; Mesalamine; Methylcellulose; Oxazines; Pectins; Solubility; Tablets, Enteric-Coated | 2002 |
Composite film-coated tablets intended for colon-specific delivery of 5-aminosalicylic acid: using deesterified pectin.
Topics: Acrylic Resins; Colon; Drug Delivery Systems; Mesalamine; Pectins; Tablets, Enteric-Coated | 2003 |
Effect of simulated gastrointestinal conditions on drug release from pectin/ethylcellulose as film coating for drug delivery to the colon.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cellulose; Colon; Delayed-Action Preparations; Gastrointestinal Transit; Humans; Hydrogen-Ion Concentration; Mesalamine; Microspheres; Models, Biological; Pectins; Time Factors | 2005 |
Preparation and in vitro evaluation of pH, time-based and enzyme-degradable pellets for colonic drug delivery.
Topics: Administration, Oral; Calcium; Cellulose; Chemistry, Pharmaceutical; Colon; Delayed-Action Preparations; Drug Delivery Systems; Excipients; Gastric Juice; Hydrogen-Ion Concentration; Mesalamine; Methacrylates; Microscopy, Electron, Scanning; Particle Size; Pectins; Polymers; Time Factors | 2007 |
Development and in-vitro evaluation of a colon-specific controlled release drug delivery system.
Topics: Cellulose; Colon; Delayed-Action Preparations; Drug Compounding; Drug Delivery Systems; Drug Stability; Drug Storage; Excipients; Hydrogen-Ion Concentration; Hypromellose Derivatives; Mesalamine; Methylcellulose; Microscopy, Scanning Probe; Pectins; Solubility; Tablets, Enteric-Coated; Time Factors | 2008 |
Box-Behnken experimental design in the development of pectin-compritol ATO 888 compression coated colon targeted drug delivery of mesalamine.
Topics: Animals; Chemistry, Pharmaceutical; Colon; Compressive Strength; Drug Delivery Systems; Drug Discovery; Excipients; Fatty Acids; Humans; Male; Mesalamine; Pectins; Rats | 2010 |
Preparation and evaluation of pectin-based colon-specific pulsatile capsule in vitro and in vivo.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Capsules; Colon; Dogs; Drug Delivery Systems; Excipients; Female; Gels; Hypromellose Derivatives; In Vitro Techniques; Lactose; Male; Mesalamine; Methylcellulose; Pectins; Pulse Therapy, Drug; Rats; Rats, Sprague-Dawley; Tablets; Time Factors | 2012 |
A novel stimuli-synchronized alloy-treated matrix for space-defined gastrointestinal delivery of mesalamine in the Large White pig model.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Barium Sulfate; beta-Glucosidase; Carboxymethylcellulose Sodium; Chemistry, Pharmaceutical; Chitosan; Colon; Cross-Linking Reagents; Drug Carriers; Mesalamine; Microscopy, Electron, Scanning; Molecular Docking Simulation; Pectins; Polygalacturonase; Polyphosphates; Polysaccharides, Bacterial; Solubility; Spectroscopy, Fourier Transform Infrared; Surface Properties; Swine | 2013 |
Pectin-coated chitosan-LDH bionanocomposite beads as potential systems for colon-targeted drug delivery.
Topics: Chitosan; Colon; Drug Delivery Systems; Hydroxides; Mesalamine; Mucins; Nanocomposites; Pectins | 2014 |
Mesalazine-probiotics beads for acetic acid experimental colitis: formulation and characterization of a promising new therapeutic strategy for ulcerative colitis.
Topics: Acetic Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Survival; Colitis, Ulcerative; Colon; Delayed-Action Preparations; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Drug Liberation; Male; Mesalamine; Particle Size; Pectins; Probiotics; Rats; Rats, Wistar | 2015 |
Effect of HPMC - E15 LV premium polymer on release profile and compression characteristics of chitosan/ pectin colon targeted mesalamine matrix tablets and in vitro study on effect of pH impact on the drug release profile.
Topics: Animals; Chitosan; Colon; Delayed-Action Preparations; Drug Delivery Systems; Drug Liberation; Hydrogen-Ion Concentration; Mesalamine; Methylcellulose; Patents as Topic; Pectins; Polymers; Rats; Tablets | 2014 |
In Vivo Evaluation of 5-ASA Colon-Specific Tablets Using Experimental-Induced Colitis Rat Animal Model.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical; Colitis; Colon; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Female; Galactans; Male; Mannans; Mesalamine; Pectins; Plant Gums; Prodrugs; Rats; Tablets; Trinitrobenzenesulfonic Acid | 2015 |
Comparative Efficacy of Chitosan, Pectin Based Mesalamine Colon Targeted Drug Delivery Systems on TNBS-induced IBD Model Rats.
Topics: Animals; Anti-Inflammatory Agents; Chitosan; Colon; Disease Models, Animal; Drug Delivery Systems; Humans; Inflammatory Bowel Diseases; Mesalamine; Pectins; Rats; Rats, Wistar; Reactive Oxygen Species; Trinitrobenzenesulfonic Acid; Ulcer | 2020 |
Bipolymeric Pectin Millibeads Doped with Functional Polymers as Matrices for the Controlled and Targeted Release of Mesalazine.
Topics: Calcium; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Gels; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kinetics; Mesalamine; Pectins; Polymers | 2020 |
Development and
Topics: Animals; Caco-2 Cells; Colitis, Ulcerative; Humans; Mesalamine; Pectins; Rats; Rats, Wistar; Saccharomyces boulardii | 2022 |
In vitro and in vivo evaluation of a pH-, microbiota- and time-based oral delivery platform for colonic release.
Topics: Animals; Chitosan; Colon; Drug Delivery Systems; Hydrogen-Ion Concentration; Inflammatory Bowel Diseases; Mesalamine; Pectins; Rats; Solubility; Tablets | 2023 |